amaxa eNews #2   Issue: amaxa eNews #1 amaxa eNews #2 amaxa eNews #3 amaxa eNews #4 amaxa eNews #5 Article: Overview Review Product Information Application Note Presentation Meetings & Shows Order more Info Related FAQs Related Citations Citations on Somatic Stem Cells and Nucleofection Identification of intrinsic determinants of midbrain dopamine neurons Authors: Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J In: Cell (2006) 124(2): 393-405 Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation Authors: Setoguchi T and Kondo T In: J Cell Biol (2004) 166(7): 963-968 Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells Authors: Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH In: Proc Natl Acad Sci USA (2004) 101(47): 16659-16664 cAMP-induced PKC activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors Authors: Goichberg P, Kalinkovich A, Borodovsky N, Tesio M, Petit I, Nagler A, Hardan I and Lapidot T In: Blood (2006) 107(3): 870-9 Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells Authors: Giebel B, Corbeil D, Beckmann J, Hohn J, Freund D, Giesen K, Fischer J, Kogler G and Wernet P In: Blood (2004) 104(8): 2332-2338 Caspase-3 has a nonapoptotic function in erythroid maturation Authors: Carlile GW, Smith DH, Wiedmann M. In: Blood (2004) 103(11): 4310-4316 Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers Authors: Potapova I, Plotnikov A, Lu Z, Danilo P Jr, Valiunas V, Qu J, Doronin S, Zuckerman J, Shlapakova IN, Gao J, Pan Z, Herron AJ, Robinson RB, Brink PR, Rosen MR and Cohen IS In: Circ Res (2004) 94(7): 952-959 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing Authors: Kalota A, Karabon L, Swider CR, Viazovkina E, Elzagheid M, Damha MJ and Gewirtz AM In: Nucleic Acids Res (2006) 34(2): 451-461 Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells Authors: Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C, Colombo MP, Versura P, D'Errico-Grigioni A, Ferri E, Baccarani M and Lemoli RM In: Stem Cells (2006) 24(2): 454-61 Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes Authors: Copray S, Balasubramaniyan V, Levenga J, de Bruijn J, Liem R and Boddeke E In: Stem Cells (2006) 24(4): 1001-1010 Transient expression of olig1 initiates the differentiation of neural stem cells into oligodendrocyte progenitor cells Authors: Balasubramaniyan V, Timmer N, Kust B, Boddeke E and Copray S In: Stem Cells (2004) 22(6): 878-882 Nucleofection, an efficient nonviral method to transfer genes into human hematopoietic stem and progenitor cells Authors: von Levetzow G, Spanholtz J, Beckmann J, Fischer J, Kogler G, Wernet P, Punzel M, Giebel B In: Stem Cells Dev (2006) 15(2): 278-85 Genetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects Authors: Papapetrou EP, Zoumbos NC and Athanassiadou A In: Gene Ther (2005) 12 Suppl 1: 118-130 Efficient gene transfer into murine embryonic stem cells by nucleofection Authors: Lorenz P, Harnack U and Morgenstern R In: Biotechnol Lett (2004) 26(20): 1589-1592 Electroporation-based gene transfer for efficient transfection of neural precursor cells Authors: Richard I, Ader M, Sytnyk V, Dityatev A, Richard G, Schachner M and Bartsch U In: Brain Res Mol Brain Res (2005) 138(2): 182-190 Highly efficient transfection of human marrow stromal cells by nucleofection Authors: Nakashima S, Matsuyama Y, Nitta A, Sakai Y and Ishiguro N In: Transplant Proc (2005) 37(5): 2290-2292 For more citations go to our citations database. Subscribe Subscribe here to receive future issues of amaxa eNews. Invite a friend Recommend amaxa's eNews to a friend or colleague.     amaxa's Nucleofection® Process, Nucleofector® Device and Nucleofector® Solutions are covered by PCT Applications PCT/EP01/07348, PCT/DE02/01489, PCT/DE02/01483, and other pending patents, and domestic or foreign applications corresponding thereto. amaxa, Nucleofector, Nucleofection and pmaxGFP are trademarks of amaxa AG. GlutaMAX is a trademark of Invitrogen. Other product and company names mentioned herein are the trademarks of their respective owners. amaxa disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, safety, or suitability of the information provided in this e-newsletter for any particular purpose. Any use of the information contained on any page of this e-newsletter is evidence of agreement with these terms of use.